Cargando…

Adjuvant Vaccination with Allogenic Dendritic Cells Significantly Prolongs Overall Survival in High-Grade Gliomas: Results of a Phase II Trial

SIMPLE SUMMARY: Among all intracranial tumors, 31.5% are malignant, and among those, glioblastomas account for 47%. Recently, our group reported the case of a patient with glioblastoma who underwent vaccination based on dendritic cells and experienced near-complete tumor remission. Here we report th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lepski, Guilherme, Bergami-Santos, Patricia C., Pinho, Mariana P., Chauca-Torres, Nadia E., Evangelista, Gabriela C. M., Teixeira, Sarah F., Flatow, Elizabeth, de Oliveira, Jaqueline V., Fogolin, Carla, Peres, Nataly, Arévalo, Analía, Alves, Venâncio A. F., Barbuto, José A. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953909/
https://www.ncbi.nlm.nih.gov/pubmed/36831580
http://dx.doi.org/10.3390/cancers15041239

Ejemplares similares